| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |